{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:16:14Z","timestamp":1776816974107,"version":"3.51.2"},"reference-count":64,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1097\/qco.0000000000000078","type":"journal-article","created":{"date-parts":[[2014,6,20]],"date-time":"2014-06-20T13:21:14Z","timestamp":1403270474000},"page":"329-335","source":"Crossref","is-referenced-by-count":22,"title":["Immunizations following solid-organ transplantation"],"prefix":"10.1097","volume":"27","author":[{"given":"Deepali","family":"Kumar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-6-20210205","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1086\/315245","article-title":"Pneumococcal vaccine response in cirrhosis and liver transplantation.","volume":"181","author":"McCashland","year":"2000","journal-title":"J Infect Dis"},{"key":"R2-6-20210205","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.2215\/CJN.04670511","article-title":"Influenza AH1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study.","volume":"6","author":"Broeders","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R3-6-20210205","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ki.2012.106","article-title":"Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination.","volume":"82","author":"Mulley","year":"2012","journal-title":"Kidney Int"},{"key":"R4-6-20210205","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1034\/j.1600-6143.2002.20315.x","article-title":"Influenza virus infection in adult solid organ transplant recipients.","volume":"2","author":"Vilchez","year":"2002","journal-title":"Am J Transplant"},{"key":"R5-6-20210205","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S1473-3099(10)70133-X","article-title":"Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study.","volume":"10","author":"Kumar","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"R6-6-20210205","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/bmj.4.5839.520","article-title":"Viral infection and renal transplant rejection.","volume":"4","author":"Briggs","year":"1972","journal-title":"Br Med J"},{"key":"R7-6-20210205","first-page":"232","article-title":"Epidemic renal transplant rejection associated with influenza A Victoria.","volume":"8","author":"Keane","year":"1978","journal-title":"Proc Clin Dial Transpl Forum"},{"key":"R8-6-20210205","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1097\/TP.0b013e3181d05a71","article-title":"A prospective molecular surveillance study evaluating the clinical impact of community-acquired respiratory viruses in lung transplant recipients.","volume":"89","author":"Kumar","year":"2010","journal-title":"Transplantation"},{"key":"R9-6-20210205","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1111\/j.1600-6143.2005.00971.x","article-title":"Clinical impact of community-acquired respiratory viruses on bronchiolitis obliterans after lung transplant.","volume":"5","author":"Kumar","year":"2005","journal-title":"Am J Transplant"},{"key":"R10-6-20210205","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/j.1600-6143.2011.03753.x","article-title":"Influenza vaccination in the organ transplant recipient: review and summary recommendations.","volume":"11","author":"Kumar","year":"2011","journal-title":"Am J Transplant"},{"key":"R11-6-20210205","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1053\/j.ajkd.2010.05.004","article-title":"Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.","volume":"56","author":"Knoll","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"R14-6-20210205","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1399-3046.2010.01433.x","article-title":"Early posttransplant vaccination with pandemic influenza AH1N1 vaccine in pediatric heart transplant recipients.","volume":"15","author":"Altamirano-Diaz","year":"2011","journal-title":"Pediatr Transplant"},{"key":"R15-6-20210205","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.ajkd.2008.09.023","article-title":"Decreased antibody response to influenza vaccination in kidney transplant recipients: a prospective cohort study.","volume":"54","author":"Birdwell","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"R16-6-20210205","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1111\/ajt.12149","article-title":"Randomized controlled trial of high-dose intradermal versus standard-dose intramuscular influenza vaccine in organ transplant recipients.","volume":"13","author":"Baluch","year":"2013","journal-title":"Am J Transplant"},{"key":"R17-6-20210205","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2215\/CJN.05430610","article-title":"Outcomes associated with influenza vaccination in the first year after kidney transplantation.","volume":"6","author":"Hurst","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R18-6-20210205","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-6143.2007.02066.x","article-title":"Influenza vaccination is efficacious and safe in renal transplant recipients.","volume":"8","author":"Scharpe","year":"2008","journal-title":"Am J Transplant"},{"key":"R19-6-20210205","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.healun.2011.01.705","article-title":"Low-dose intradermal versus intramuscular trivalent inactivated seasonal influenza vaccine in lung transplant recipients.","volume":"30","author":"Manuel","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R20-6-20210205","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1111\/j.1600-6143.2007.01982.x","article-title":"Immunogenicity and safety of an intradermal boosting strategy for vaccination against influenza in lung transplant recipients.","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"key":"R21-6-20210205","first-page":"1075","article-title":"Safety of influenza vaccine in heart transplant recipients.","volume":"17","author":"Blumberg","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"R22-6-20210205","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/clinids\/22.2.295","article-title":"The immunogenicity of influenza virus vaccine in solid organ transplant recipients.","volume":"22","author":"Blumberg","year":"1996","journal-title":"Clin Infect Dis"},{"key":"R23-6-20210205","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/S0264-410X(97)00193-X","article-title":"Antibody response to influenza immunization in patients after heart transplantation.","volume":"15","author":"Admon","year":"1997","journal-title":"Vaccine"},{"key":"R24-6-20210205","doi-asserted-by":"crossref","first-page":"7522","DOI":"10.1016\/j.vaccine.2012.10.047","article-title":"Effect of two injections of nonadjuvanted influenza A H1N1pdm2009 vaccine in renal transplant recipients: INSERM C09-32 TRANSFLUVAC trial.","volume":"30","author":"Le Corre","year":"2012","journal-title":"Vaccine"},{"key":"R25-6-20210205","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/nm.3409","article-title":"Key roles of adjuvants in modern vaccines.","volume":"19","author":"Reed","year":"2013","journal-title":"Nat Med"},{"key":"R26-6-20210205","doi-asserted-by":"crossref","first-page":"3363","DOI":"10.1016\/j.vaccine.2013.05.007","article-title":"The adjuvant effect of MF59 is due to the oil-in-water emulsion formulation, none of the individual components induce a comparable adjuvant effect.","volume":"31","author":"Calabro","year":"2013","journal-title":"Vaccine"},{"key":"R27-6-20210205","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/j.1399-3062.2012.00769.x","article-title":"Antibody response to the nonadjuvanted and adjuvanted influenza A H1N109 monovalent vaccines in renal transplant recipients.","volume":"14","author":"Salles","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R28-6-20210205","doi-asserted-by":"crossref","first-page":"893","DOI":"10.3851\/IMP2103","article-title":"Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine.","volume":"17","author":"Siegrist","year":"2012","journal-title":"Antivir Ther"},{"key":"R29-6-20210205","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2215\/CJN.02160311","article-title":"Efficacy of influenza A H1N12009 vaccine in hemodialysis and kidney transplant patients.","volume":"6","author":"Crespo","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"R30-6-20210205","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s00430-012-0231-8","article-title":"Serological response to influenza A H1N1 vaccine (Pandemrix(R)) and seasonal influenza vaccine 20092010 in renal transplant recipients and in hemodialysis patients.","volume":"201","author":"Ott","year":"2012","journal-title":"Med Microbiol Immunol"},{"key":"R31-6-20210205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1093\/ndt\/gfr278","article-title":"Immune response to an adjuvanted influenza A H1N1 vaccine (Pandemrix((R))) in renal transplant recipients.","volume":"27","author":"Brakemeier","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R32-6-20210205","first-page":"485","article-title":"Licensure of a high-dose inactivated influenza vaccine for persons aged or= 65 yea 65 years (Fluzone high-dose) and guidance for use - United States, 2010.","volume":"59","year":"2010","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"R33-6-20210205","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1111\/j.1600-6143.2009.02787.x","article-title":"Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients.","volume":"9","author":"Candon","year":"2009","journal-title":"Am J Transplant"},{"key":"R34-6-20210205","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1111\/j.1600-6143.2011.03604.x","article-title":"De novo anti-HLA antibody after pandemic H1N1 and seasonal influenza immunization in kidney transplant recipients.","volume":"11","author":"Katerinis","year":"2011","journal-title":"Am J Transplant"},{"key":"R35-6-20210205","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/tid.12006","article-title":"Poor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.","volume":"14","author":"Fairhead","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R36-6-20210205","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1111\/j.1600-6143.2011.03743.x","article-title":"Impact of adjuvanted H1N1 vaccine on cell-mediated rejection in heart transplant recipients.","volume":"11","author":"Schaffer","year":"2011","journal-title":"Am J Transplant"},{"key":"R37-6-20210205","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1111\/j.1600-6143.2006.01705.x","article-title":"Invasive pneumococcal disease in solid organ transplant recipients - 10-year prospective population surveillance.","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"R38-6-20210205","first-page":"816","article-title":"13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"61","year":"2012","journal-title":"MMWR Morbid Mortal Wkly Rep"},{"key":"R40-6-20210205","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1086\/374784","article-title":"Randomized, double-blind, controlled trial of pneumococcal vaccination in renal transplant recipients.","volume":"187","author":"Kumar","year":"2003","journal-title":"J Infect Dis"},{"key":"R41-6-20210205","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1600-6143.2007.01668.x","article-title":"Immunogenicity of pneumococcal vaccine in renal transplant recipients - three year follow-up of a randomized trial.","volume":"7","author":"Kumar","year":"2007","journal-title":"Am J Transplant"},{"key":"R42-6-20210205","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1086\/591537","article-title":"A randomized, double-blind, placebo-controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in adult liver transplant recipients.","volume":"47","author":"Kumar","year":"2008","journal-title":"Clin Infect Dis"},{"key":"R43-6-20210205","doi-asserted-by":"crossref","first-page":"e46133","DOI":"10.1371\/journal.pone.0046133","article-title":"Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.","volume":"7","author":"Tobudic","year":"2012","journal-title":"PLoS One"},{"key":"R44-6-20210205","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1542\/peds.2004-2312","article-title":"Safety and immunogenicity of the American Academy of Pediatrics - recommended sequential pneumococcal conjugate and polysaccharide vaccine schedule in pediatric solid organ transplant recipients.","volume":"116","author":"Lin","year":"2005","journal-title":"Pediatrics"},{"key":"R45-6-20210205","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/archderm.142.7.943","article-title":"Varicella infection caused by Oka strain vaccine in a heart transplant recipient.","volume":"142","author":"Kraft","year":"2006","journal-title":"Arch Dermatol"},{"key":"R46-6-20210205","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1111\/j.1600-6143.2012.04273.x","article-title":"Varicella-Zoster immunization in pediatric liver transplant recipients: safe and immunogenic.","volume":"12","author":"Posfay-Barbe","year":"2012","journal-title":"Am J Transplant"},{"key":"R47-6-20210205","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1600-6143.2005.01210.x","article-title":"Safety and immunogenicity of Varicella-Zoster virus vaccine in pediatric liver and intestine transplant recipients.","volume":"6","author":"Weinberg","year":"2006","journal-title":"Am J Transplant"},{"key":"R48-6-20210205","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12519-008-0047-1","article-title":"Efficacy and safety of Measles, Mumps, Rubella and Varicella live viral vaccines in transplant recipients receiving immunosuppressive drugs.","volume":"4","author":"Danerseau","year":"2008","journal-title":"World J Pediatr"},{"key":"R49-6-20210205","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1046\/j.1600-6143.2003.00287.x","article-title":"Herpes Zoster infection following solid organ transplantation: incidence, risk factors and outcomes in the current immunosuppressive era.","volume":"4","author":"Gourishankar","year":"2004","journal-title":"Am J Transplant"},{"key":"R50-6-20210205","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.healun.2007.09.028","article-title":"Incidence and clinical characteristics of Herpes Zoster after lung transplantation.","volume":"27","author":"Manuel","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R51-6-20210205","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.athoracsur.2008.11.004","article-title":"Herpes Zoster after lung transplantation: incidence, timing, and outcome.","volume":"87","author":"Fuks","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"R52-6-20210205","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1056\/NEJMoa051016","article-title":"A vaccine to prevent Herpes Zoster and postherpetic neuralgia in older adults.","volume":"352","author":"Oxman","year":"2005","journal-title":"N Engl J Med"},{"key":"R53-6-20210205","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1093\/cid\/cir970","article-title":"Efficacy, safety, and tolerability of Herpes Zoster vaccine in persons aged 50-59 years.","volume":"54","author":"Schmader","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R54-6-20210205","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/jmv.21784","article-title":"Human papillomavirus infection in urine samples from male renal transplant patients.","volume":"82","author":"Tornesello","year":"2010","journal-title":"J Med Virol"},{"key":"R55-6-20210205","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1093\/oxfordjournals.ndt.a027621","article-title":"Low prevalence of human papillomavirus infection of the cervix in renal transplant recipients.","volume":"11","author":"Morrison","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"R56-6-20210205","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1523\/JNEUROSCI.06-11-03128.1986","article-title":"Somatostatin, an inhibitor of ACTH secretion, decreases cytosolic free calcium and voltage-dependent calcium current in a pituitary cell line.","volume":"6","author":"Luini","year":"1986","journal-title":"J Neurosci"},{"key":"R57-6-20210205","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1111\/ajt.12472","article-title":"HPV-related cancers after solid organ transplantation in the United States.","volume":"13","author":"Madeleine","year":"2013","journal-title":"Am J Transplant"},{"key":"R58-6-20210205","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1056\/NEJMoa0909537","article-title":"Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males.","volume":"364","author":"Giuliano","year":"2011","journal-title":"N Engl J Med"},{"key":"R59-6-20210205","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1056\/NEJMoa061760","article-title":"Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases.","volume":"356","author":"Garland","year":"2007","journal-title":"N Engl J Med"},{"key":"R60-6-20210205","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/S0140-6736(09)60691-7","article-title":"Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24-45 years: a randomised, double-blind trial.","volume":"373","author":"Munoz","year":"2009","journal-title":"Lancet"},{"key":"R61-6-20210205","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/petr.12226","article-title":"Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients.","volume":"18","author":"Gomez-Lobo","year":"2014","journal-title":"Pediatr Transplant"},{"key":"R62-6-20210205","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1111\/ajt.12329","article-title":"Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients.","volume":"13","author":"Kumar","year":"2013","journal-title":"Am J Transplant"},{"key":"R63-6-20210205","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1872-034X.2012.01102.x","article-title":"Immunogenicity of different hepatitis B virus vaccination schedules in liver transplant recipients.","volume":"43","author":"Feng","year":"2013","journal-title":"Hepatol Res"},{"key":"R64-6-20210205","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1034\/j.1600-6143.2002.21014.x","article-title":"Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients.","volume":"2","author":"Choy","year":"2002","journal-title":"Am J Transplant"},{"key":"R65-6-20210205","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/ajt.12032","article-title":"Meningococcal sepsis complicating eculizumab treatment despite prior vaccination.","volume":"13","author":"Struijk","year":"2013","journal-title":"Am J Transplant"},{"key":"R66-6-20210205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1111\/j.1399-3062.2011.00686.x","article-title":"Yellow fever vaccination in organ transplanted patients: is it safe A multicenter study.","volume":"14","author":"Azevedo","year":"2012","journal-title":"Transpl Infect Dis"},{"key":"R67-6-20210205","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1111\/ajt.12338","article-title":"Persistence of yellow fever vaccine-induced antibodies after solid organ transplantation.","volume":"13","author":"Wyplosz","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Current Opinion in Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/QCO.0000000000000078","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T22:45:17Z","timestamp":1716849917000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001432-201408000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":64,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/qco.0000000000000078","relation":{},"ISSN":["0951-7375"],"issn-type":[{"value":"0951-7375","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]}}}